California Lawmakers Pass Bill Decriminalizing Select Psychedelics and Mandating Therapeutic Research
If passed, the possession, use, and cultivation of certain natural psychedelic substances would be decriminalized starting in 2025.
On September 7th, 2023, lawmakers in California approved Senate Bill 58, which aims to decriminalize the limited possession and personal use and cultivation of certain psychedelic substances: psilocybin, psilocin, mescaline, and dimethyltryptamine (DMT) (1). The bill passed with a vote of 21-14 (2). Also included in the bill is the requirement for the California Health and Human Services Agency to study and report on the therapeutic potential of psychedelic substances (1). A workgroup would be created to facilitate the research and make the regulatory framework to access the substances (2).
After amendments to the original version of the bill, this bill does not include 3,4-Methylenedioxymethamphetamine (MDMA), lysergic acid diethylamide (LSD), and ibogaine on the list of decriminalized substances (1).
“California’s veterans, first responders, and others struggling with PTSD, depression, and addiction deserve access to these promising plant medicines,” Senator Scott Wiener had stated after the bill passed the Assembly on September 6th (2). “It’s time to stop criminalizing people who use psychedelics for healing or personal well-being….SB 58 has prudent safeguards in place after we incorporated feedback from three years of deep engagement with a broad array of stakeholders.”
The bill applies only to adults over 21 years of age, and personal transfer and sales is dispensaries are not permitted (1).
“This is just very basic, people should not be criminalized if they are using personal possession of these substances,” said Jesse Gould, a veteran and sponsor of SB 58 (1). “If people are choosing to do that in their own privacy, they should absolutely be able to have that ability.”
The bill will be approved or denied by October 14 by Governor Gavin Newson, and if approved, will go into effect on the first day of 2025 (2). Newsom has reportedly not declared an opinion in favor or against the legislation (3). As noted in SB 58, the cities of Oakland and Santa Cruz, have already passed measures decriminalizing certain psychedelic substances (1).
References
- Wiley, H. California moves to decriminalize use of magic mushrooms and other natural psychedelics https://www.latimes.com/california/story/2023-09-07/california-magic-mushrooms-psychedelics-scott-wiener-psilocybin (accessed Sep 15, 2023).
- Jaeger, K. California psychedelics legalization bill is officially heading to governor’s desk after final Senate passage https://www.marijuanamoment.net/california-psychedelics-legalization-bill-is-officially-heading-to-governors-desk-after-final-senate-passage/ (accessed Sep 15, 2023).
- Jaeger, K. California assembly approves psychedelics legalization bill with amendments, sending it back to the Senate for Final passage https://www.marijuanamoment.net/california-assembly-approves-psychedelics-legalization-bill-with-amendments-sending-it-back-to-the-senate-for-final-passage/ (accessed Sep 15, 2023).
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
